# FDA Inspection 1256062 - Ralph A DeFronzo, MD - December 06, 2024

Source: https://www.keypedia.com/records/fda_inspections/ralph-a-defronzo-md/937f0630-28a6-46b3-b7b2-c6625e28f2b3
Source feed: FDA_Inspections

> FDA Inspection 1256062 for Ralph A DeFronzo, MD on December 06, 2024. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1256062
- Company Name: Ralph A DeFronzo, MD
- Inspection Date: 2024-12-06
- Classification: Official Action Indicated (OAI)
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Office Name: Dallas District Office

## Related Documents

- [FDA Inspection 1256062 - 2024-12-06](https://www.keypedia.com/records/fda_inspections/ralph-a-defronzo-md/4c3e7940-4b9d-443b-b0c8-ce68b1eeda04)
- [FDA Inspection 804900 - 2012-10-19](https://www.keypedia.com/records/fda_inspections/ralph-a-defronzo-md/85df5096-05cc-4390-aa41-ffc438fc1a7c)

Company: https://www.keypedia.com/companies/ralph-a-defronzo-md/436fd75e-9d0b-43bf-98cc-e438be0ac043

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9